In particular, KRAS is one of the most frequently mutated oncogenes across cancer types: KRAS mutations occur in approximately 60–70% of pancreatic cancers, 30% of colorectal and biliary cancers, and 20% of lung and ovarian cancers [1]–[3]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.